Stock 002252 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shanghai RAAS Blood Products Co., Ltd.

Equities

002252

CNE100000C31

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
7.08 CNY -0.42% Intraday chart for Shanghai RAAS Blood Products Co., Ltd. -3.28% -11.50%
May. 14 GRIFOLS CEO SAYS CAN CONFIRM SHANGHAI RAAS TRANSACTION WILL CLO… RE
Apr. 29 Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shanghai Raas Blood Products Co., Ltd. Approves 2023 Profit Distribution Plan
CI
GRIFOLS CEO SAYS CAN CONFIRM SHANGHAI RAAS TRANSACTION WILL CLO…
RE
Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth
MT
Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Grifols to refinance debt due in 2025 via sales of notes, Shanghai RAAS stake
RE
RAAS Blood Products Gets Regulatory Nod to Trial Drug for Bleeding Disorders
MT
Grifols says due diligence was carried out on Shanghai RAAS stake sale
RE
Grifols' shares tumble as restructuring costs hit annual profit
RE
S&P Maintains Grifols' Rating, Stable Outlook Amid Expected Deleveraging
MT
S&P keeps Grifols at 'B+', sees leverage decreasing in 2024
RE
ECB probes banks over exposure to Spanish drugmaker Grifols: sources
RE
ECB sounds out lenders on exposure to Spanish drugmaker Grifols - sources
RE
The Ibex-35 rebounds without leaving the range of the last month and a half.
RE
Grifols Wins Assurance from Haier for Shanghai RAAS Stake Deal
MT
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
RE
GRIFOLS: HAIER GROUP'S CHAIRWOMAN SAYS COMPANY CONTINUES TO WOR…
RE
Grifols shares suffer worst week on record after short-seller report
RE
Grifols foresees no problems in the sale of its stake in China despite Gotham City's report
RE
Grifols to Finalize $1.8 Billion Shanghai RAAS Stake Sale as Planned in H1
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002252 Stock
  4. News Shanghai RAAS Blood Products Co., Ltd.